Concepedia

John Ilgenfritz

JI

Statistics

Publications

8

Citations

536

H-Index

8

Active since

1988

Affiliations

Boehringer Ingelheim (Germany)(Current)

Uppsala University

University of Mannheim

McMaster University

Bristol-Myers Squibb (United States)

John Ilgenfritz is an author at Boehringer Ingelheim (Germany) specializing in medicine, cardiovascular disease, and gastrointestinal bleeding.

Top concepts

Publications per year

1988–2018

8

Publications

8

Matrix-Applied Characterized Autologous Cultured Chondrocytes Versus Microfracture: Five-Year Follow-up of a Prospective Randomized Trial

Mats Brittberg, David P. Recker, John Ilgenfritz et al. · The American Journal of Sports Medicine · 2018 · 271 citations

, , +22

Fosinopril attenuates clinical deterioration and improves exercise tolerance in patients with heart failure

Leif Erhardt, Anne MacLean, John Ilgenfritz et al. · European Heart Journal · 1995 · 89 citations

Major Gastrointestinal Bleeding Often Is Caused by Occult Malignancy in Patients Receiving Warfarin or Dabigatran to Prevent Stroke and Systemic Embolism From Atrial Fibrillation

K.F. Flack, Jay Desai, Jennifer M. Kolb et al. · Clinical Gastroenterology and Hepatology · 2016 · 58 citations

, , +13

Effects of fosinopril on exercise tolerance and clinical deterioration in patients with chronic congestive heart failure not taking digitalis

Edward J. Brown, Paul H. Chew, Anne MacLean et al. · The American Journal of Cardiology · 1995 · 39 citations

, , +12

A cautionary note on the use of chemstrips for detection of blood residues on prehistoric stone tools

Jay F. Custer, John Ilgenfritz, Keith R. Doms · Journal of Archaeological Science · 1988 · 29 citations

, , +9

1–5 of 8